M shows promise with 55 effectiveness in trials Learn how this breakthrough could revolutionize malaria prevention ...

The RH5.1/Matrix-M blood-stage malaria vaccine shows promise as a crucial secondary defence against malaria, complementing ...

Following positive Phase IIb trial results, RH5.1/Matrix-M could be the first blood-stage malaria vaccine brought to market.

"These crippled parasites are administered through a mosquito bite and reach the human liver as usual," says vaccinologist ...

Congo’s health ministry told Reuters this week that malaria was the culprit: “The mystery has finally been solved. It’s a ...

An initially "unknown" illness affecting hundreds in the Democratic Republic of the Congo may be attributable to malaria, ...

Nigeria is the latest African country to give a new malaria vaccine to young childen. The country began its vaccination ...

A blood-stage malaria vaccine would not replace pre-erythrocytic vaccines, but provide a second line of defence.

The first blood-stage malaria vaccine RH5.1/Matrix-M has the potential to be a component within a developing malaria vaccine strategy, said a report on Thursday.

The jab targets parasites after they pass through the liver and into the blood, which is the stage that causes symptoms ...

A mystery illness found in a remote part of Congo has been officially identified as a severe form of malaria, which has ...

Olugbenga Mokuolu is a professor of paediatrics at the University of Ilorin Teaching Hospital and the current Strategic ...